Fluoroquinolone resistance in uncomplicated acute pyelonephritis: Epidemiology and clinical impact

Microbial Drug Resistance

Volumn 18, Issue 2, 2012, Pages 169-175

  Shin, Jaehyun ^a   Kim, Jieun ^b   Wie, Seong Heon ^c   Cho, Young Kyun ^d   Lim, Seung Kwan ^e   Shin, Sang Yop ^f   Yeom, Joon Sup ^g   Lee, Jin Seo ^h   Kweon, Ki Tae ⁱ   Lee, Hyuck ^j   Cheong, Hee Jin ^k   Park, Sun Hee ^l   Park, Dae Won ^k   Ryu, Seong Yeol ^m   Chung, Moon Hyun ⁿ   Yoo, Sunmi ^o   Pai, Hyunjoo ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b Hanyang University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Gachon University   (South Korea)

^e Ajou University School of Medicine   (South Korea)

^f Jeju National University Hospital   (South Korea)

^g Sungkyunkwan University School of Medicine   (South Korea)

^h Hallym University   (South Korea)

ⁱ Patima Hospital   (South Korea)

^j Dong A University   (South Korea)

^k Korea University Ansan Hospital   (South Korea)

^l Daejeon University   (South Korea)

^m Department of Internal Medicine   (South Korea)

ⁿ Inha University Hospital   (South Korea)

^o Inje University College of Medicine   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; SULTAMICILLIN; TOBRAMYCIN; TRIMETHOPRIM;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DISEASE COURSE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS; SOUTH KOREA; STREPTOCOCCUS; TREATMENT OUTCOME; UNCOMPLICATED ACUTE PYELONEPHRITIS;

ACUTE DISEASE; ADULT; AGED; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PYELONEPHRITIS; REPUBLIC OF KOREA; TREATMENT OUTCOME; URINE;

ESCHERICHIA COLI;

EID: 84859593125     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0139     Document Type: Article

References (15)

1. Clinical and Laboratory Standard Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing: 15th Informational Supplement: Approved Standard M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Fang, G.D., C. Brennen, M. Wagener, D. Swanson, M. Hilf, L. Zadecky, J. DeVine, and V.L. Yu. 1991. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: Prospective, randomized clinical and pharmacokinetic study. Antimicrob. Agents Chemother. 35:1849-1855.
3. Gupta, K., D.F. Sahm, D. Mayfield, and W.E. Stamm. 2001. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationalwide analysis. Clin. Infect. Dis. 33:89-94. (Pubitemid 32554508)
4. Gupta, K., T.M. Hooton, K.G. Naber, B. Wult, R. Colgan, L.G. Miller, G.J. Moran, L.E. Nicolle, R. Raz, A.J. Schaeffer, and D.E. Soper. 2011. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52:e103-e120.
5. Hooton, T.M. 2003. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int. J. Antimicrob. Agents 22:565-572.
6. Johnson, L., A. Sabel, W.J. Burman, R.M. Everhart, M. Rome, T.D. MacKenzie, J. Rozwadowski, P.S. Mehler, and C.S. Price. 2008. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli. Am. J. Med. 121:876-884.
7. Kahlmeter, G. 2000. The ECO-SENS project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemother. 46(Suppl.1):15-22.
8. Kim, M.E., U.S. Ha, and Y.U. Cho. 2008. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: A multicentre study in 2006. Int. J. Antimicrob. Agents 31S:S15-S18.
9. Lee, S.S., Y. Kim, and D.R. Chung. 2011. Impact of discordant empirical therapy on outcome of communityacquired bacteremic acute pyelonephritis. J. Infect. 62:159-164.
10. Masterton, R.G., and J.A. Bochsler. 1995. High-dosage coamoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J. Antimicrob. Chemother. 35:129-137.
11. McCarty, J.M., G. Richard, W. Huch, R.M. Tucker, R.L. Tosiellol, M. Shan, A. Heyd, and R.M. Echols. 1999. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am. J. Med. 106:292-299. (Pubitemid 29153406)
12. Sobel, J.D., and D. Kaye. 2010. Urinary tract infections. In Madell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, seventh edition. Chrchill Livingstone Elsevier, Philadelphia, PA, pp. 966-967.
13. Stamey, T.A., W.R. Fair, M.M. Timothy, M.A. Millar, G. Mihara, and Y.C. Lowery. 1974. Serum versus urinary an-timicrobial concentrations in cure of urinary-tract infections. N. Engl. J. Med. 291:1159-1163.
14. Talan, D.A., W.E. Stamm, T.M. Hooton, G.J. Moran, T. Burke, A. Iravani, J. Reuning-Scherer, and D.A. Church. 2000. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial. JAMA 283: 1583-1590. (Pubitemid 30161514)
15. York, M.K. 2004. Aerobic Bacteriology. In Isenberg, H.D. (ed.), Clinical Microbiology Procedures Handbook, 2nd edition. ASM press, Washington, DC, 3.12.1-3.12.15.